{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:59:09Z","timestamp":1795042749135,"version":"4.10.2"},"reference-count":221,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202429, 82102938"],"award-info":[{"award-number":["82202429, 82102938"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2022KY551"],"award-info":[{"award-number":["2022KY551"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00794-8","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:35:45Z","timestamp":1759916145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epitranscriptomic modifications in programmed cell death: mechanistic insights and implications for liver diseases"],"prefix":"10.1186","volume":"30","author":[{"given":"Lulu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoli","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"issue":"1","key":"794_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12943-020-01194-6","volume":"19","author":"H Shi","year":"2020","unstructured":"Shi H, Chai P, Jia R, Fan X. Novel insight into the regulatory roles of diverse RNA modifications: re-defining the bridge between transcription and translation. Mol Cancer. 2020;19(1):78.","journal-title":"Mol Cancer"},{"issue":"11","key":"794_CR2","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41587-021-00949-w","volume":"39","author":"PN Pratanwanich","year":"2021","unstructured":"Pratanwanich PN, Yao F, Chen Y, Koh CWQ, Wan YK, Hendra C, et al. Identification of differential RNA modifications from nanopore direct RNA sequencing with xPore. Nat Biotechnol. 2021;39(11):1394\u2013402.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"794_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","volume":"9","author":"Z Yang","year":"2022","unstructured":"Yang Z, Yu GL, Zhu X, Peng TH, Lv YC. Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders. Genes Dis. 2022;9(1):51\u201361.","journal-title":"Genes Dis"},{"issue":"1","key":"794_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12943-022-01704-8","volume":"22","author":"X Cao","year":"2023","unstructured":"Cao X, Geng Q, Fan D, Wang Q, Wang X, Zhang M, et al. M(6)A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. Mol Cancer. 2023;22(1):42.","journal-title":"Mol Cancer"},{"issue":"1","key":"794_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12929-021-00734-6","volume":"28","author":"YP Yen","year":"2021","unstructured":"Yen YP, Chen JA. The m(6)A epitranscriptome on neural development and degeneration. J Biomed Sci. 2021;28(1):40.","journal-title":"J Biomed Sci"},{"issue":"1","key":"794_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","volume":"21","author":"Y An","year":"2022","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14.","journal-title":"Mol Cancer"},{"issue":"2","key":"794_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","volume":"22","author":"D Wiener","year":"2021","unstructured":"Wiener D, Schwartz S. The epitranscriptome beyond m(6)A. Nat Rev Genet. 2021;22(2):119\u201331.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"794_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12943-024-02194-6","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li L, Mendoza JJ, Wang D, Yan Q, Shi L, et al. Advances in A-to-I RNA editing in cancer. Mol Cancer. 2024;23(1):280.","journal-title":"Mol Cancer"},{"issue":"10","key":"794_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tcb.2024.08.002","volume":"34","author":"B Akg\u00fcl","year":"2024","unstructured":"Akg\u00fcl B, Ak\u00e7a\u00f6z-Alasar A, Sa\u011flam B. RNA m(6)A methylation at the juxtaposition of apoptosis and RNA therapeutics. Trends Cell Biol. 2024;34(10):801\u20134.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"794_CR10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ymthe.2024.01.037","volume":"32","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Lin LC, Liu ZY, Yang JJ, Tao H. m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis. Mol Ther. 2024;32(4):878\u201389.","journal-title":"Mol Ther"},{"key":"794_CR11","doi-asserted-by":"publisher","first-page":"982606","DOI":"10.3389\/fcell.2022.982606","volume":"10","author":"JCT Cheung","year":"2022","unstructured":"Cheung JCT, Deng G, Wong N, Dong Y, Ng SSM. More than a duologue: in-depth insights into epitranscriptomics and ferroptosis. Front Cell Dev Biol. 2022;10:982606.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"794_CR12","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523.","journal-title":"Nat Commun"},{"issue":"1","key":"794_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13045-024-01545-6","volume":"17","author":"S Zhou","year":"2024","unstructured":"Zhou S, Liu J, Wan A, Zhang Y, Qi X. Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis. J Hematol Oncol. 2024;17(1):22.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"794_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25(5):379\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"794_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","volume":"21","author":"S Bedoui","year":"2020","unstructured":"Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21(11):678\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"794_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/procel\/pwae003","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao C, Wang M, Zhuang L, Gan B. Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell. 2024;15(9):642\u201360.","journal-title":"Protein Cell"},{"key":"794_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071765","author":"L Gibellini","year":"2021","unstructured":"Gibellini L, Moro L. Programmed cell death in health and disease. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10071765.","journal-title":"Cells"},{"issue":"5","key":"794_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41419-022-04923-5","volume":"13","author":"M Li","year":"2022","unstructured":"Li M, Wang ZW, Fang LJ, Cheng SQ, Wang X, Liu NF. Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis. 2022;13(5):467.","journal-title":"Cell Death Dis"},{"key":"794_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121885","author":"Y Rajesh","year":"2022","unstructured":"Rajesh Y, Kanneganti TD. Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11121885.","journal-title":"Cells"},{"issue":"2","key":"794_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337.","journal-title":"J Hepatol"},{"issue":"5","key":"794_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.jhep.2021.01.046","volume":"74","author":"M Reig","year":"2021","unstructured":"Reig M, Cabibbo G. Antiviral therapy in the palliative setting of HCC (BCLC-B and-C). J Hepatol. 2021;74(5):1225\u201333.","journal-title":"J Hepatol"},{"key":"794_CR22","doi-asserted-by":"publisher","first-page":"154203","DOI":"10.1016\/j.metabol.2020.154203","volume":"111","author":"SA Polyzos","year":"2020","unstructured":"Polyzos SA, Kang ES, Boutari C, Rhee EJ, Mantzoros CS. Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. Metab. 2020;111:154203.","journal-title":"Metab"},{"issue":"1","key":"794_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"794_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","volume":"79","author":"L Rimassa","year":"2023","unstructured":"Rimassa L, Finn RS, Sangro B. Combination immunotherapy for hepatocellular carcinoma. J Hepatol. 2023;79(2):506\u201315.","journal-title":"J Hepatol"},{"issue":"12","key":"794_CR25","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","volume":"21","author":"LY Mak","year":"2024","unstructured":"Mak LY, Liu K, Chirapongsathorn S, Yew KC, Tamaki N, Rajaram RB, et al. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nat Rev Gastroenterol Hepatol. 2024;21(12):834\u201351.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"794_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"794_CR27","doi-asserted-by":"publisher","first-page":"101037","DOI":"10.1016\/j.xplc.2024.101037","volume":"5","author":"J Hu","year":"2024","unstructured":"Hu J, Xu T, Kang H. Crosstalk between RNA m(6)A modification and epigenetic factors in plant gene regulation. Plant Commun. 2024;5(10):101037.","journal-title":"Plant Commun"},{"key":"794_CR28","doi-asserted-by":"publisher","unstructured":"\u0106orovi\u0107 M, Hoch-Kraft P, Zhou Y, Hallstein S, K\u00f6nig J, Zarnack K. m(6)A in the coding sequence: linking deposition, translation, and decay. Trends Genet. 2025. https:\/\/doi.org\/10.1016\/j.tig.2025.06.002.","DOI":"10.1016\/j.tig.2025.06.002"},{"key":"794_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.06.030","author":"S Kumar","year":"2025","unstructured":"Kumar S, Sinha M. Targeting intracellular mRNA m(6)A-modifiers in advancing immunotherapeutics. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.06.030.","journal-title":"J Adv Res"},{"key":"794_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.05.021","author":"NI Vlachogiannis","year":"2025","unstructured":"Vlachogiannis NI, Polycarpou-Schwarz M, Avdi AP, Tual-Chalot S, Stellos K. Targeting RNA adenosine editing and modification enzymes for RNA therapeutics. Mol Ther. 2025. https:\/\/doi.org\/10.1016\/j.ymthe.2025.05.021.","journal-title":"Mol Ther"},{"issue":"1","key":"794_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12964-025-02254-4","volume":"23","author":"Y Han","year":"2025","unstructured":"Han Y, Sun J, Yao M, Miao L, Li M. Biological roles of enhancer RNA m6A modification and its implications in cancer. Cell Commun Signal. 2025;23(1):254.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"794_CR32","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41594-025-01548-y","volume":"32","author":"A Penning","year":"2025","unstructured":"Penning A, Jeschke J, Fuks F. The importance of physiological and disease contexts in capturing mRNA modifications. Nat Struct Mol Biol. 2025;32(5):780\u20139.","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"794_CR33","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1016\/j.ymthe.2022.07.020","volume":"30","author":"Y Li","year":"2022","unstructured":"Li Y, Kang X, Zhou Z, Pan L, Chen H, Liang X, et al. The m(6)A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. Mol Ther. 2022;30(12):3714\u201328.","journal-title":"Mol Ther"},{"key":"794_CR34","doi-asserted-by":"publisher","first-page":"1447135","DOI":"10.3389\/fcell.2024.1447135","volume":"12","author":"Z Liao","year":"2024","unstructured":"Liao Z, Wang J, Xu M, Li X, Xu H. The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis. Front Cell Dev Biol. 2024;12:1447135.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"794_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70239","volume":"15","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li Y, Li L, Yao F, Cai M, Ye D, et al. Detection, molecular function and mechanisms of m5C in cancer. Clin Transl Med. 2025;15(3):e70239.","journal-title":"Clin Transl Med"},{"issue":"1","key":"794_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-1139-1","volume":"18","author":"T Amort","year":"2017","unstructured":"Amort T, Rieder D, Wille A, Khokhlova-Cubberley D, Riml C, Trixl L, et al. Distinct 5-methylcytosine profiles in poly(A) RNA from mouse embryonic stem cells and brain. Genome Biol. 2017;18(1):1.","journal-title":"Genome Biol"},{"key":"794_CR37","doi-asserted-by":"publisher","first-page":"1351964","DOI":"10.1155\/2018\/1351964","volume":"2018","author":"Z Wei","year":"2018","unstructured":"Wei Z, Panneerdoss S, Timilsina S, Zhu J, Mohammad TA, Lu ZL, et al. Topological characterization of human and mouse m(5)C epitranscriptome revealed by bisulfite sequencing. Int J Genomics. 2018;2018:1351964.","journal-title":"Int J Genomics"},{"key":"794_CR38","doi-asserted-by":"publisher","first-page":"1599305","DOI":"10.3389\/fimmu.2025.1599305","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Yuan Y, Zhou F, Huang X, Li L, Pu J, et al. RNA m5C modification: from physiology to pathology and its biological significance. Front Immunol. 2025;16:1599305.","journal-title":"Front Immunol"},{"issue":"1","key":"794_CR39","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"WW Liu","year":"2024","unstructured":"Liu WW, Zheng SQ, Li T, Fei YF, Wang C, Zhang S, et al. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther. 2024;9(1):70.","journal-title":"Signal Transduct Target Ther"},{"key":"794_CR40","doi-asserted-by":"publisher","first-page":"122372","DOI":"10.1016\/j.lfs.2023.122372","volume":"338","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Xing C, Peng H. ALYREF (Aly\/REF export factor): a potential biomarker for predicting cancer occurrence and therapeutic efficacy. Life Sci. 2024;338:122372.","journal-title":"Life Sci"},{"key":"794_CR41","doi-asserted-by":"publisher","first-page":"1533148","DOI":"10.3389\/fcell.2025.1533148","volume":"13","author":"X Hu","year":"2025","unstructured":"Hu X, Liu Y, Zhang S, Liu K, Gu X. The multifaceted role of m5C RNA methylation in digestive system tumorigenesis. Front Cell Dev Biol. 2025;13:1533148.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"794_CR42","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1021\/acs.analchem.9b04505","volume":"92","author":"X Dai","year":"2020","unstructured":"Dai X, Gonzalez G, Li L, Li J, You C, Miao W, et al. YTHDF2 binds to 5-methylcytosine in RNA and modulates the maturation of ribosomal RNA. Anal Chem. 2020;92(1):1346\u201354.","journal-title":"Anal Chem"},{"issue":"1","key":"794_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-025-07414-5","volume":"16","author":"Q Qi","year":"2025","unstructured":"Qi Q, Zhong R, Huang Y, Tang Y, Zhang XW, Liu C, et al. The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated glycolysis. Cell Death Dis. 2025;16(1):82.","journal-title":"Cell Death Dis"},{"issue":"1","key":"794_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijbs.82316","volume":"20","author":"J Nulali","year":"2024","unstructured":"Nulali J, Zhang K, Long M, Wan Y, Liu Y, Zhang Q, et al. ALYREF-mediated RNA 5-methylcytosine modification promotes hepatocellular carcinoma progression via stabilizing EGFR mRNA and pSTAT3 activation. Int J Biol Sci. 2024;20(1):331\u201346.","journal-title":"Int J Biol Sci"},{"key":"794_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70026","volume":"512","author":"Z Gu","year":"2024","unstructured":"Gu Z, Zou L, Pan X, Yu Y, Liu Y, Zhang Z, et al. The role and mechanism of NAT10-mediated ac4C modification in tumor development and progression. MedComm. 2024;512:e70026.","journal-title":"MedComm"},{"key":"794_CR46","doi-asserted-by":"publisher","first-page":"115628","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo J, Cao J, Chen C, Xie H. Emerging role of RNA acetylation modification ac4C in diseases: current advances and future challenges. Biochem Pharmacol. 2023;213:115628.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"794_CR47","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1038\/emboj.2008.154","volume":"27","author":"Y Ikeuchi","year":"2008","unstructured":"Ikeuchi Y, Kitahara K, Suzuki T. The RNA acetyltransferase driven by ATP hydrolysis synthesizes N4-acetylcytidine of tRNA anticodon. EMBO J. 2008;27(16):2194\u2013203.","journal-title":"EMBO J"},{"issue":"4","key":"794_CR48","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1093\/nar\/gkv075","volume":"43","author":"S Sharma","year":"2015","unstructured":"Sharma S, Langhendries JL, Watzinger P, K\u00f6tter P, Entian KD, Lafontaine DL. Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1\/THUMPD1. Nucleic Acids Res. 2015;43(4):2242\u201358.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"794_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006804","volume":"13","author":"S Sharma","year":"2017","unstructured":"Sharma S, Yang J, van Nues R, Watzinger P, K\u00f6tter P, Lafontaine DLJ, et al. Specialized box C\/D snoRNPs act as antisense guides to target RNA base acetylation. PLoS Genet. 2017;13(5):e1006804.","journal-title":"PLoS Genet"},{"issue":"9","key":"794_CR50","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/cac2.12595","volume":"44","author":"H Liu","year":"2024","unstructured":"Liu H, Xu L, Yue S, Su H, Chen X, Liu Q, et al. Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation. Cancer Commun. 2024;44(9):1018\u201341.","journal-title":"Cancer Commun"},{"issue":"4","key":"794_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s42764-021-00046-x","volume":"2","author":"C Xu","year":"2021","unstructured":"Xu C, Zhang J, Zhang J, Liu B. SIRT7 is a deacetylase of N4-acetylcytidine on ribosomal RNA. Genome Instabil Dis. 2021;2(4):253\u201360.","journal-title":"Genome Instabil Dis"},{"key":"794_CR52","doi-asserted-by":"publisher","first-page":"102030","DOI":"10.1016\/j.molmet.2024.102030","volume":"89","author":"Y Yang","year":"2024","unstructured":"Yang Y, Lu J, Liu Y, Zhang N, Luo Y, Ma M, et al. Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10. Mol Metab. 2024;89:102030.","journal-title":"Mol Metab"},{"issue":"1","key":"794_CR53","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12944-024-02360-1","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wan X, Khan MA, Peng L, Sun X, Yi X, et al. NAT10 promotes liver lipogenesis in mouse through N4-acetylcytidine modification of Srebf1 and Scap mRNA. Lipids Health Dis. 2024;23(1):368.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"794_CR54","doi-asserted-by":"publisher","first-page":"e701","DOI":"10.1002\/ctm2.70190","volume":"15","author":"S Jia","year":"2025","unstructured":"Jia S, Yu X, Deng N, Zheng C, Ju M, Wang F, et al. Deciphering the pseudouridine nucleobase modification in human diseases: from molecular mechanisms to clinical perspectives. Clin Transl Med. 2025;15(1):e701\u201390.","journal-title":"Clin Transl Med"},{"issue":"6","key":"794_CR55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.tips.2022.03.008","volume":"43","author":"J Cerneckis","year":"2022","unstructured":"Cerneckis J, Cui Q, He C, Yi C, Shi Y. Decoding pseudouridine: an emerging target for therapeutic development. Trends Pharmacol Sci. 2022;43(6):522\u201335.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"794_CR56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/nar\/gkaa1178","volume":"49","author":"O Levi","year":"2021","unstructured":"Levi O, Arava YS. Pseudouridine-mediated translation control of mRNA by methionine aminoacyl tRNA synthetase. Nucleic Acids Res. 2021;49(1):432\u201343.","journal-title":"Nucleic Acids Res"},{"key":"794_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biom10060841","author":"K Jayalath","year":"2020","unstructured":"Jayalath K, Frisbie S, To M, Abeysirigunawardena S. Pseudouridine synthase RsuA captures an assembly intermediate that is stabilized by ribosomal protein S17. Biomol. 2020. https:\/\/doi.org\/10.3390\/biom10060841.","journal-title":"Biomol"},{"issue":"5","key":"794_CR58","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/HEP.0000000000000702","volume":"80","author":"YX Hu","year":"2024","unstructured":"Hu YX, Diao LT, Hou YR, Lv G, Tao S, Xu WY, et al. Pseudouridine synthase 1 promotes hepatocellular carcinoma through mrna pseudouridylation to enhance the translation of oncogenic mrnas. Hepatol. 2024;80(5):1058\u201373.","journal-title":"Hepatol"},{"issue":"5","key":"794_CR59","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.30039","volume":"68","author":"E Ko","year":"2018","unstructured":"Ko E, Kim JS, Ju S, Seo HW, Chang Y, Kang JA, et al. Oxidatively modified protein-disulfide isomerase-associated 3 promotes dyskerin pseudouridine synthase 1-mediated malignancy and survival of hepatocellular carcinoma cells. Hepatol. 2018;68(5):1851\u201364.","journal-title":"Hepatol"},{"issue":"11","key":"794_CR60","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1093\/nar\/gkaa305","volume":"48","author":"AA Schaffer","year":"2020","unstructured":"Schaffer AA, Kopel E, Hendel A, Picardi E, Levanon EY, Eisenberg E. The cell line A-to-I RNA editing catalogue. Nucleic Acids Res. 2020;48(11):5849\u201358.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"794_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14621-5","volume":"11","author":"SJ Tang","year":"2020","unstructured":"Tang SJ, Shen H, An O, Hong H, Li J, Song Y, et al. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development. Nat Commun. 2020;11(1):799.","journal-title":"Nat Commun"},{"issue":"6252","key":"794_CR62","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.aac7049","volume":"349","author":"BJ Liddicoat","year":"2015","unstructured":"Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Sci. 2015;349(6252):1115\u201320.","journal-title":"Sci"},{"issue":"9","key":"794_CR63","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1261\/rna.080097.124","volume":"30","author":"K Rou\u010dov\u00e1","year":"2024","unstructured":"Rou\u010dov\u00e1 K, Vop\u00e1lensk\u00fd V, Ma\u0161ek T, Del Llano E, Provazn\u00edk J, Landry JJM, et al. Loss of ADAR1 protein induces changes in small RNA landscape in hepatocytes. RNA. 2024;30(9):1164\u201383.","journal-title":"RNA"},{"issue":"8","key":"794_CR64","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41423-021-00729-1","volume":"18","author":"L Wang","year":"2021","unstructured":"Wang L, Sun Y, Song X, Wang Z, Zhang Y, Zhao Y, et al. Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes. Cell Mol Immunol. 2021;18(8):1871\u201382.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"794_CR65","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/gutjnl-2012-304037","volume":"63","author":"TH Chan","year":"2014","unstructured":"Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut. 2014;63(5):832\u201343.","journal-title":"Gut"},{"issue":"1","key":"794_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41570-019-0147-6","volume":"4","author":"WA Velema","year":"2020","unstructured":"Velema WA, Kool ET. The chemistry and applications of RNA 2\u2032-OH acylation. Nat Rev Chem. 2020;4(1):22-37\u2032.","journal-title":"Nat Rev Chem"},{"issue":"9","key":"794_CR67","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41557-023-01246-6","volume":"15","author":"L Fang","year":"2023","unstructured":"Fang L, Xiao L, Jun YW, Onishi Y, Kool ET. Reversible 2\u2019-OH acylation enhances RNA stability. Nat Chem. 2023;15(9):1296\u2013305.","journal-title":"Nat Chem"},{"issue":"1","key":"794_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12964-023-01401-z","volume":"22","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang S, Gao X, Ru Y, Gu X, Hu X. Research progress of N1-methyladenosine RNA modification in cancer. Cell Commun Signal. 2024;22(1):79.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"794_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01285-5","volume":"15","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yao Y, Wu P, Zi X, Sun N, He J. The potential role of N(7)-methylguanosine (m7G) in cancer. J Hematol Oncol. 2022;15(1):63.","journal-title":"J Hematol Oncol"},{"issue":"12","key":"794_CR70","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1016\/j.molcel.2024.04.011","volume":"84","author":"Y Li","year":"2024","unstructured":"Li Y, Yi Y, Gao X, Wang X, Zhao D, Wang R, et al. 2\u2032-O-methylation at internal sites on mRNA promotes mRNA stability. Mol Cell. 2024;84(12):2320-36.e6.","journal-title":"Mol Cell"},{"issue":"9","key":"794_CR71","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41419-021-04128-2","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Wang X, Huang Z, Zhou Y, Xia J, Hu W, et al. Cisd3 inhibition drives cystine-deprivation induced ferroptosis. Cell Death Dis. 2021;12(9):839.","journal-title":"Cell Death Dis"},{"issue":"7","key":"794_CR72","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41419-021-03996-y","volume":"12","author":"J Du","year":"2021","unstructured":"Du J, Wang X, Li Y, Ren X, Zhou Y, Hu W, et al. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism. Cell Death Dis. 2021;12(7):705.","journal-title":"Cell Death Dis"},{"issue":"1","key":"794_CR73","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12964-024-01520-1","volume":"22","author":"J Du","year":"2024","unstructured":"Du J, Yu L, Yang X, Shao F, Xia J, Jin W, et al. Regulation of NCOA4-mediated iron recycling ameliorates paraquat-induced lung injury by inhibiting ferroptosis. Cell Commun Signal. 2024;22(1):146.","journal-title":"Cell Commun Signal"},{"key":"794_CR74","doi-asserted-by":"publisher","first-page":"103007","DOI":"10.1016\/j.redox.2023.103007","volume":"69","author":"P Zhang","year":"2024","unstructured":"Zhang P, Zhou C, Ren X, Jing Q, Gao Y, Yang C, et al. Inhibiting the compensatory elevation of xCT collaborates with disulfiram\/copper-induced GSH consumption for cascade ferroptosis and cuproptosis. Redox Biol. 2024;69:103007.","journal-title":"Redox Biol"},{"issue":"22","key":"794_CR75","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289(22):7038\u201350.","journal-title":"FEBS J"},{"issue":"1","key":"794_CR76","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00018-025-05812-8","volume":"82","author":"X Ding","year":"2025","unstructured":"Ding X, Cui L, Mi Y, Hu J, Cai Z, Tang Q, et al. Ferroptosis in cancer: revealing the multifaceted functions of mitochondria. Cell Mol Life Sci. 2025;82(1):277.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"794_CR77","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41418-024-01270-0","volume":"31","author":"Y Du","year":"2024","unstructured":"Du Y, Zhou Y, Yan X, Pan F, He L, Guo Z, et al. APE1 inhibition enhances ferroptotic cell death and contributes to hepatocellular carcinoma therapy. Cell Death Differ. 2024;31(4):431\u201346.","journal-title":"Cell Death Differ"},{"issue":"2","key":"794_CR78","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC, et al. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol. 2023;79(2):362\u201377.","journal-title":"J Hepatol"},{"issue":"1","key":"794_CR79","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10142-025-01579-0","volume":"25","author":"A El-Sehrawy","year":"2025","unstructured":"El-Sehrawy A, Rashid TA, Ullah MI, Uthirapathy S, Ganesan S, Singh A, et al. Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy. Funct Integr Genomics. 2025;25(1):71.","journal-title":"Funct Integr Genomics"},{"key":"794_CR80","doi-asserted-by":"publisher","first-page":"103194","DOI":"10.1016\/j.redox.2024.103194","volume":"74","author":"D Wu","year":"2024","unstructured":"Wu D, Spencer CB, Ortoga L, Zhang H, Miao C. Histone lactylation-regulated METTL3 promotes ferroptosis via m6A-modification on ACSL4 in sepsis-associated lung injury. Redox Biol. 2024;74:103194.","journal-title":"Redox Biol"},{"issue":"9","key":"794_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1389","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wu D, Wang Y, Guo K, Spencer CB, Ortoga L, et al. METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury. Clin Transl Med. 2023;13(9):e1389.","journal-title":"Clin Transl Med"},{"key":"794_CR82","doi-asserted-by":"crossref","unstructured":"Jing H, Song J, Sun J, Su S, Hu J, Zhang H, et al. METTL3 governs thymocyte development and thymic involution by regulating ferroptosis. Nat Aging. 2024;4(12):1813\u201327.","DOI":"10.1038\/s43587-024-00724-x"},{"key":"794_CR83","doi-asserted-by":"publisher","first-page":"111495","DOI":"10.1016\/j.intimp.2024.111495","volume":"128","author":"F Chen","year":"2024","unstructured":"Chen F, Su M, Han D, Wang Y, Song M. METTL14 depletion ameliorates ferroptosis in severe acute pancreatitis by increasing the N6-methyladenosine modification of ACSL4 and STA1. Int Immunopharmacol. 2024;128:111495.","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"794_CR84","doi-asserted-by":"publisher","first-page":"298","DOI":"10.31083\/j.fbl2908298","volume":"29","author":"X Gu","year":"2024","unstructured":"Gu X, Song Y, Liu X, Cheng Z, Min J, Zhang Y. METTL14-mediated m6A modification of TUG1 represses ferroptosis in Alzheimer\u2032s disease via inhibiting GDF15 ubiquitination. Front Biosci. 2024;29(8):298.","journal-title":"Front Biosci"},{"key":"794_CR85","doi-asserted-by":"publisher","first-page":"103067","DOI":"10.1016\/j.redox.2024.103067","volume":"70","author":"Y Yang","year":"2024","unstructured":"Yang Y, Ren J, Zhang J, Shi H, Wang J, Yan Y. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53\u2013P21\/Nrf2 activation in a HuR-dependent m6A manner. Redox Biol. 2024;70:103067.","journal-title":"Redox Biol"},{"key":"794_CR86","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.freeradbiomed.2024.05.014","volume":"220","author":"J Zhou","year":"2024","unstructured":"Zhou J, Tang J, Zhang C, Li G, Lin X, Liao S, et al. ALKBH5 targets ACSL4 mRNA stability to modulate ferroptosis in hyperbilirubinemia-induced brain damage. Free Radic Biol Med. 2024;220:271\u201387.","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"794_CR87","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jin P, Wang X. N(6)-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A\/PD-L1 manner. Apoptosis. 2024;29(1\u20132):142\u201353.","journal-title":"Apoptosis"},{"issue":"12","key":"794_CR88","doi-asserted-by":"publisher","first-page":"nwad227","DOI":"10.1093\/nsr\/nwad227","volume":"10","author":"J Lin","year":"2023","unstructured":"Lin J, Zhan G, Liu J, Maimaitiyiming Y, Deng Z, Li B, et al. YTHDF2-mediated regulations bifurcate BHPF-induced programmed cell deaths. Natl Sci Rev. 2023;10(12):nwad227.","journal-title":"Natl Sci Rev"},{"key":"794_CR89","doi-asserted-by":"publisher","first-page":"111660","DOI":"10.1016\/j.cellsig.2025.111660","volume":"130","author":"W Peng","year":"2025","unstructured":"Peng W, Liang J, Qian X, Li M, Nie M, Chen B. IGF2BP1\/AIFM2 axis regulates ferroptosis and glycolysis to drive hepatocellular carcinoma progression. Cell Signal. 2025;130:111660.","journal-title":"Cell Signal"},{"key":"794_CR90","doi-asserted-by":"publisher","first-page":"102975","DOI":"10.1016\/j.redox.2023.102975","volume":"69","author":"SJ Chen","year":"2024","unstructured":"Chen SJ, Zhang J, Zhou T, Rao SS, Li Q, Xiao LY, et al. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA. Redox Biol. 2024;69:102975.","journal-title":"Redox Biol"},{"issue":"11","key":"794_CR91","doi-asserted-by":"publisher","first-page":"114885","DOI":"10.1016\/j.celrep.2024.114885","volume":"43","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang Y, Li R, Li Y, Wang Q, Wang Y, et al. STUB1-mediated ubiquitination and degradation of NSUN2 promotes hepatocyte ferroptosis by decreasing m(5)c methylation of Gpx4 mRNA. Cell Rep. 2024;43(11):114885.","journal-title":"Cell Rep"},{"issue":"7","key":"794_CR92","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41419-024-06882-5","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Hu J, Xiong X, Chen H, Liao Q, Lin B, et al. SETD8 inhibits apoptosis and ferroptosis of Ewing\u2019s sarcoma through YBX1\/RAC3 axis. Cell Death Dis. 2024;15(7):494.","journal-title":"Cell Death Dis"},{"issue":"46","key":"794_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202407012","volume":"11","author":"Q Li","year":"2024","unstructured":"Li Q, Guo G, Chen Y, Lu L, Li H, Zhou Z, et al. HCP5 derived novel microprotein triggers progression of gastric cancer through regulating ferroptosis. Adv Sci. 2024;11(46):e2407012.","journal-title":"Adv Sci"},{"key":"794_CR94","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuroscience.2022.08.009","volume":"501","author":"S Rashad","year":"2022","unstructured":"Rashad S, Byrne SR, Saigusa D, Xiang J, Zhou Y, Zhang L, et al. Codon usage and mRNA stability are translational determinants of cellular response to canonical ferroptosis inducers. Neurosci. 2022;501:103\u201330.","journal-title":"Neurosci"},{"issue":"12","key":"794_CR95","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, et al. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun. 2022;42(12):1347\u201366.","journal-title":"Cancer Commun"},{"issue":"10","key":"794_CR96","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1111\/cas.16249","volume":"115","author":"Z Xue","year":"2024","unstructured":"Xue Z, Xie H, Shan Y, Zhang L, Cheng L, Chen W, et al. NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma. Cancer Sci. 2024;115(10):3256\u201372.","journal-title":"Cancer Sci"},{"issue":"48","key":"794_CR97","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","volume":"43","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li J, Xu J, Long Y, Wang Y, Liu X, et al. m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation. Oncog. 2024;43(48):3498\u2013516.","journal-title":"Oncog"},{"issue":"12","key":"794_CR98","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/mc.23818","volume":"63","author":"D He","year":"2024","unstructured":"He D, Niu C, Bai R, Chen N, Cui J. ADAR1 promotes invasion and migration and inhibits ferroptosis via the FAK\/AKT pathway in colorectal cancer. Mol Carcinog. 2024;63(12):2401\u201313.","journal-title":"Mol Carcinog"},{"key":"794_CR99","doi-asserted-by":"publisher","first-page":"111258","DOI":"10.1016\/j.cellsig.2024.111258","volume":"121","author":"C Yin","year":"2024","unstructured":"Yin C, Zhang MM, Wang GL, Deng XY, Tu Z, Jiang SS, et al. Loss of ADAR1 induces ferroptosis of breast cancer cells. Cell Signal. 2024;121:111258.","journal-title":"Cell Signal"},{"issue":"1","key":"794_CR100","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s13046-023-02906-8","volume":"42","author":"C Xu","year":"2023","unstructured":"Xu C, Bian Z, Wang X, Niu N, Liu L, Xiao Y, et al. SNORA56-mediated pseudouridylation of 28 S rRNA inhibits ferroptosis and promotes colorectal cancer proliferation by enhancing GCLC translation. J Exp Clin Cancer Res. 2023;42(1):331.","journal-title":"J Exp Clin Cancer Res"},{"key":"794_CR101","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.biopha.2023.115522","volume":"167","author":"G Lei","year":"2023","unstructured":"Lei G, Tang L, Yu Y, Bian W, Yu L, Zhou J, et al. The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma. Biomed Pharmacother. 2023;167:115522.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"794_CR102","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12935-025-03864-1","volume":"25","author":"C Luo","year":"2025","unstructured":"Luo C, Wu X, Zhang S, Tan J, Huo Y, Zhang X, et al. Cuproptosis: a novel therapeutic mechanism in lung cancer. Cancer Cell Int. 2025;25(1):231.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"794_CR103","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, et al. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduct Target Ther. 2025;10(1):149.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"794_CR104","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.cmet.2024.07.009","volume":"36","author":"Y Li","year":"2024","unstructured":"Li Y, Ma J, Wang R, Luo Y, Zheng S, Wang X. Zinc transporter 1 functions in copper uptake and cuproptosis. Cell Metab. 2024;36(9):2118-29.e6.","journal-title":"Cell Metab"},{"key":"794_CR105","doi-asserted-by":"publisher","first-page":"116585","DOI":"10.1016\/j.biopha.2024.116585","volume":"174","author":"Y Li","year":"2024","unstructured":"Li Y, Qi P, Song SY, Wang Y, Wang H, Cao P, et al. Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease. Biomed Pharmacother. 2024;174:116585.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"794_CR106","doi-asserted-by":"publisher","first-page":"110601","DOI":"10.1016\/j.ygeno.2023.110601","volume":"115","author":"L Guowei","year":"2023","unstructured":"Guowei L, Xiufang L, Qianqian X, Yanping J. The FDX1 methylation regulatory mechanism in the malignant phenotype of glioma. Genomics. 2023;115(2):110601.","journal-title":"Genomics"},{"issue":"40","key":"794_CR107","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1038\/s41388-024-03139-5","volume":"43","author":"K Du","year":"2024","unstructured":"Du K, Luo Y, Zhang L, Zeng Y, Dai Y, Ren M, et al. M(6)A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis. Oncogene. 2024;43(40):2971\u201385.","journal-title":"Oncogene"},{"issue":"3","key":"794_CR108","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00432-025-06163-4","volume":"151","author":"M Shu","year":"2025","unstructured":"Shu M, Guo K, Huang Y, Wang W. Nsun5 promotes cholangiocarcinoma progression by enhancing GLS mrna stabilization. J Cancer Res Clin Oncol. 2025;151(3):117.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"794_CR109","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"Liu X, Nie L, Zhang Y, Yan Y, Wang C, Colic M, et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat Cell Biol. 2023;25(3):404\u201314.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"794_CR110","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s11658-025-00743-5","volume":"30","author":"Y Liu","year":"2025","unstructured":"Liu Y, Li S, Wu Y, Zhang P, Yu Y, Chen X, et al. Molecular signatures of disulfidptosis: interplay with programmed cell death pathways and therapeutic implications in oncology. Cell Mol Biol Lett. 2025;30(1):66.","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"794_CR111","first-page":"188955","volume":"1878","author":"X Wang","year":"2023","unstructured":"Wang X, Lin J, Li Z, Wang M. In what area of biology has a \u201cnew\u201d type of cell death been discovered? Biochem Biophys Acta. 2023;1878(5):188955.","journal-title":"Biochem Biophys Acta"},{"key":"794_CR112","doi-asserted-by":"publisher","first-page":"123168","DOI":"10.1016\/j.biomaterials.2025.123168","volume":"319","author":"H Tian","year":"2025","unstructured":"Tian H, Deng H, Liu X, Liu C, Zhang C, Leong KW, et al. A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma. Biomater. 2025;319:123168.","journal-title":"Biomater"},{"key":"794_CR113","doi-asserted-by":"publisher","first-page":"cbm230276","DOI":"10.3233\/CBM-230276","volume":"42","author":"K Xie","year":"2024","unstructured":"Xie K, Wang B, Pang P, Li G, Yang Q, Fang C, et al. A novel disulfidptosis-related prognostic gene signature and experimental validation identify ACTN4 as a novel therapeutic target in lung adenocarcinoma. Cancer Biomark. 2024;42:cbm230276.","journal-title":"Cancer Biomark"},{"issue":"1","key":"794_CR114","doi-asserted-by":"publisher","first-page":"16268","DOI":"10.1038\/s41598-023-43414-1","volume":"13","author":"Q Xia","year":"2023","unstructured":"Xia Q, Yan Q, Wang Z, Huang Q, Zheng X, Shen J, et al. Disulfidptosis-associated lncRNAs predict breast cancer subtypes. Sci Rep. 2023;13(1):16268.","journal-title":"Sci Rep"},{"key":"794_CR115","doi-asserted-by":"publisher","DOI":"10.3390\/biom14010136","author":"H Abbas","year":"2024","unstructured":"Abbas H, Derkaoui DK, Jeammet L, Adic\u00e9am E, Tiollier J, Sicard H, et al. Apoptosis inhibitor 5: a multifaceted regulator of cell fate. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14010136.","journal-title":"Biomolecules"},{"key":"794_CR116","doi-asserted-by":"publisher","first-page":"216662","DOI":"10.1016\/j.canlet.2024.216662","volume":"585","author":"U Biswas","year":"2024","unstructured":"Biswas U, Roy R, Ghosh S, Chakrabarti G. The interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics. Cancer Lett. 2024;585:216662.","journal-title":"Cancer Lett"},{"issue":"1","key":"794_CR117","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","volume":"81","author":"KR LeFort","year":"2024","unstructured":"LeFort KR, Rungratanawanich W, Song BJ. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cell Mol Life Sci. 2024;81(1):34.","journal-title":"Cell Mol Life Sci"},{"key":"794_CR118","doi-asserted-by":"publisher","first-page":"144076","DOI":"10.1016\/j.gene.2019.144076","volume":"722","author":"H Wang","year":"2020","unstructured":"Wang H, Xu B, Shi J. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene. 2020;722:144076.","journal-title":"Gene"},{"issue":"1","key":"794_CR119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","volume":"13","author":"Q Wang","year":"2020","unstructured":"Wang Q, Geng W, Guo H, Wang Z, Xu K, Chen C, et al. Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer. J Hematol Oncol. 2020;13(1):57.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"794_CR120","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.ymthe.2022.01.002","volume":"30","author":"L Jiang","year":"2022","unstructured":"Jiang L, Liu X, Hu X, Gao L, Zeng H, Wang X, et al. METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Mol Ther. 2022;30(4):1721\u201340.","journal-title":"Mol Ther"},{"issue":"12","key":"794_CR121","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl5723","volume":"8","author":"T Zhang","year":"2022","unstructured":"Zhang T, Ding C, Chen H, Zhao J, Chen Z, Chen B, et al. M(6)A mRNA modification maintains colonic epithelial cell homeostasis via NF-\u03baB-mediated antiapoptotic pathway. Sci Adv. 2022;8(12):eabl5723.","journal-title":"Sci Adv"},{"issue":"1","key":"794_CR122","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s10020-021-00365-5","volume":"27","author":"M Li","year":"2021","unstructured":"Li M, Deng L, Xu G. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of \u03b1-klotho. Mol Med. 2021;27(1):106.","journal-title":"Mol Med"},{"issue":"1","key":"794_CR123","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun L, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18(1):46.","journal-title":"Mol Cancer"},{"issue":"12","key":"794_CR124","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.7150\/ijbs.84768","volume":"19","author":"MY Ke","year":"2023","unstructured":"Ke MY, Fang Y, Cai H, Lu JW, Yang L, Wang Y, et al. The m(6)A reader YTHDF1 attenuates fulminant hepatitis via MFG-E8 translation in an m(6)A dependent manner. Int J Biol Sci. 2023;19(12):3987\u20134003.","journal-title":"Int J Biol Sci"},{"issue":"15","key":"794_CR125","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/j.molcel.2021.06.014","volume":"81","author":"JM Einstein","year":"2021","unstructured":"Einstein JM, Perelis M, Chaim IA, Meena JK, Nussbacher JK, Tankka AT, et al. Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer. Mol Cell. 2021;81(15):3048-64.e9.","journal-title":"Mol Cell"},{"issue":"10","key":"794_CR126","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35(10):1782-98.e8.","journal-title":"Cell Metab"},{"key":"794_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154986","volume":"253","author":"X Shen","year":"2024","unstructured":"Shen X, Sun H, Shu S, Tang W, Yuan Y, Su H, et al. Suppression of NSUN2 enhances the sensitivity to chemosensitivity and inhibits proliferation by mediating cell apoptosis in gastric cancer. Pathol Res Pract. 2024;253:154986.","journal-title":"Pathol Res Pract"},{"issue":"11","key":"794_CR128","first-page":"4757","volume":"15","author":"L Li","year":"2023","unstructured":"Li L, Li M, Zheng J, Li Z, Chen X. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway. Aging. 2023;15(11):4757\u201373.","journal-title":"Aging"},{"issue":"1","key":"794_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01814-x","volume":"22","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang M, Xu J, Yu D, Li Y, Chen Y, et al. LINC02159 promotes non-small cell lung cancer progression via ALYREF\/YAP1 signaling. Mol Cancer. 2023;22(1):122.","journal-title":"Mol Cancer"},{"issue":"3","key":"794_CR130","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15252\/embr.201540505","volume":"17","author":"X Liu","year":"2016","unstructured":"Liu X, Tan Y, Zhang C, Zhang Y, Zhang L, Ren P, et al. NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2. EMBO Rep. 2016;17(3):349\u201366.","journal-title":"EMBO Rep"},{"issue":"1","key":"794_CR131","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, et al. Acetyltransferase NAT10 regulates the Wnt\/\u03b2-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022;41(1):345.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"794_CR132","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12890-024-03463-2","volume":"25","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Li N, Zhu J, Shao C, Zeng X, Yi D. Role of NAT10-mediated ac(4)C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells. BMC Pulm Med. 2025;25(1):75.","journal-title":"BMC Pulm Med"},{"key":"794_CR133","doi-asserted-by":"publisher","first-page":"1576651","DOI":"10.3389\/fonc.2025.1576651","volume":"15","author":"L Chen","year":"2025","unstructured":"Chen L, Tan Y, Li W, Huang L, Li K, Feng Z, et al. Pseudouridine synthase 1 promotes progression of hepatocellular carcinoma via mTOR and MYC signaling pathways. Front Oncol. 2025;15:1576651.","journal-title":"Front Oncol"},{"issue":"4","key":"794_CR134","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s10620-021-06936-0","volume":"67","author":"J Du","year":"2022","unstructured":"Du J, Gong A, Zhao X, Wang G. Pseudouridylate synthase 7 promotes cell proliferation and invasion in colon cancer through activating PI3K\/AKT\/mTOR signaling pathway. Dig Dis Sci. 2022;67(4):1260\u201370.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"794_CR135","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12967-021-02827-0","volume":"19","author":"G Kan","year":"2021","unstructured":"Kan G, Wang Z, Sheng C, Yao C, Mao Y, Chen S. Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma. J Transl Med. 2021;19(1):161.","journal-title":"J Transl Med"},{"issue":"7920","key":"794_CR136","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","volume":"607","author":"R de Reuver","year":"2022","unstructured":"de Reuver R, Verdonck S, Dierick E, Nemegeer J, Hessmann E, Ahmad S, et al. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation. Nature. 2022;607(7920):784\u20139.","journal-title":"Nature"},{"issue":"2","key":"794_CR137","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3892\/ijo.2016.3823","volume":"50","author":"YB Chen","year":"2017","unstructured":"Chen YB, Liao XY, Zhang JB, Wang F, Qin HD, Zhang L, et al. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma. Int J Oncol. 2017;50(2):622\u201330.","journal-title":"Int J Oncol"},{"key":"794_CR138","doi-asserted-by":"publisher","first-page":"8399","DOI":"10.2147\/JIR.S524246","volume":"18","author":"Y Chen","year":"2025","unstructured":"Chen Y, Chen R, Ji X, Zeng Z, Guan C. Nlrp3 inflammasome-mediated pyroptosis in diabetic nephropathy: pathogenic mechanisms and therapeutic targets. J Inflamm Res. 2025;18:8399\u2013418.","journal-title":"J Inflamm Res"},{"issue":"3","key":"794_CR139","doi-asserted-by":"publisher","first-page":"C784","DOI":"10.1152\/ajpcell.00503.2023","volume":"326","author":"G Imre","year":"2024","unstructured":"Imre G. Pyroptosis in health and disease. Am J Physiol Cell Physiol. 2024;326(3):C784\u201394.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"794_CR140","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41422-025-01107-6","volume":"35","author":"P Broz","year":"2025","unstructured":"Broz P. Pyroptosis: molecular mechanisms and roles in disease. Cell Res. 2025;35(5):334\u201344.","journal-title":"Cell Res"},{"key":"794_CR141","doi-asserted-by":"publisher","first-page":"107754","DOI":"10.1016\/j.phrs.2025.107754","volume":"216","author":"DF Shang","year":"2025","unstructured":"Shang DF, Xu WQ, Zhao Q, Zhao CL, Wang SY, Han YL, et al. Molecular mechanisms of pyroptosis in non-alcoholic steatohepatitis and feasible diagnosis and treatment strategies. Pharmacol Res. 2025;216:107754.","journal-title":"Pharmacol Res"},{"key":"794_CR142","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.cellsig.2024.111572","volume":"127","author":"Q Yang","year":"2025","unstructured":"Yang Q, Xiao J, Liu Y, Yang Z, Wang C, Sun J, et al. METTL3-mediated m6A modifications of NLRP3 accelerate alveolar bone resorption through enhancing macrophage pyroptosis. Cell Signal. 2025;127:111572.","journal-title":"Cell Signal"},{"issue":"9","key":"794_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1405","volume":"13","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhao Z, Ying P, Zhou Y, Xu Z, Wang H, et al. METTL3-mediated m(6)a modification of circPRKAR1B promotes Crohn\u2019s colitis by inducing pyroptosis via autophagy inhibition. Clin Transl Med. 2023;13(9):e1405.","journal-title":"Clin Transl Med"},{"issue":"1","key":"794_CR144","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41420-021-00756-x","volume":"7","author":"B Shu","year":"2021","unstructured":"Shu B, Zhou YX, Li H, Zhang RZ, He C, Yang X. The METTL3\/MALAT1\/PTBP1\/USP8\/TAK1 axis promotes pyroptosis and M1 polarization of macrophages and contributes to liver fibrosis. Cell Death Discov. 2021;7(1):368.","journal-title":"Cell Death Discov"},{"issue":"1","key":"794_CR145","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","volume":"13","author":"L Meng","year":"2022","unstructured":"Meng L, Lin H, Huang X, Weng J, Peng F, Wu S. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA. Cell Death Dis. 2022;13(1):38.","journal-title":"Cell Death Dis"},{"issue":"1","key":"794_CR146","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-022-00350-8","volume":"27","author":"J Lan","year":"2022","unstructured":"Lan J, Xu B, Shi X, Pan Q, Tao Q. WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy. Cell Mol Biol Lett. 2022;27(1):51.","journal-title":"Cell Mol Biol Lett"},{"issue":"2","key":"794_CR147","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7150\/ijbs.78348","volume":"19","author":"Y Mao","year":"2023","unstructured":"Mao Y, Jiang F, Xu XJ, Zhou LB, Jin R, Zhuang LL, et al. Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1\/MIF pathway. Int J Biol Sci. 2023;19(2):593\u2013609.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"794_CR148","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-022-00872-2","volume":"8","author":"S Zhang","year":"2022","unstructured":"Zhang S, Guan X, Liu W, Zhu Z, Jin H, Zhu Y, et al. YTHDF1 alleviates sepsis by upregulating WWP1 to induce NLRP3 ubiquitination and inhibit caspase-1-dependent pyroptosis. Cell Death Discov. 2022;8(1):244.","journal-title":"Cell Death Discov"},{"issue":"2","key":"794_CR149","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s12035-023-03622-2","volume":"61","author":"H Yan","year":"2024","unstructured":"Yan H, Huang W, Rao J, Yan D, Yuan J. Demethylase FTO-mediated m6A modification of lncRNA MEG3 activates neuronal pyroptosis via NLRP3 signaling in cerebral ischemic stroke. Mol Neurobiol. 2024;61(2):1023\u201343.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"794_CR150","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/s42003-022-03868-x","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang H, Chen Z, Zhou J, Gu J, Wu H, Jiang Y, et al. NAT10 regulates neutrophil pyroptosis in sepsis via acetylating ULK1 RNA and activating STING pathway. Commun Biol. 2022;5(1):916.","journal-title":"Commun Biol"},{"issue":"5","key":"794_CR151","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/SHK.0000000000002551","volume":"63","author":"K Gao","year":"2025","unstructured":"Gao K, Yang X, Zhao W, Lin Y, Hu B, Wang D. NAT10 promotes pyroptosis and pancreatic injury of severe acute pancreatitis through AC4C modification of NLRP3. Shock. 2025;63(5):774\u201380.","journal-title":"Shock"},{"key":"794_CR152","doi-asserted-by":"publisher","first-page":"68","DOI":"10.25259\/Cytojournal_72_2024","volume":"21","author":"L Wang","year":"2024","unstructured":"Wang L, Huang J, Song L, Ke B. N-acetyltransferase 10 regulates UNC-51-like kinase 1 to reduce tubular cell injury and kidney stone formation. Cytojournal. 2024;21:68.","journal-title":"Cytojournal"},{"issue":"2","key":"794_CR153","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7150\/ijbs.86424","volume":"20","author":"X Zhao","year":"2024","unstructured":"Zhao X, Xie J, Duan C, Wang L, Si Y, Liu S, et al. ADAR1 protects pulmonary macrophages from sepsis-induced pyroptosis and lung injury through miR-21\/A20 signaling. Int J Biol Sci. 2024;20(2):464\u201385.","journal-title":"Int J Biol Sci"},{"key":"794_CR154","doi-asserted-by":"publisher","first-page":"145909","DOI":"10.1016\/j.gene.2021.145909","volume":"805","author":"Z Li","year":"2021","unstructured":"Li Z, Zhu J, Wang Y. Adar3 alleviated inflammation and pyroptosis of neuropathic pain by targeting NLRP3 in chronic constriction injury mice. Gene. 2021;805:145909.","journal-title":"Gene"},{"key":"794_CR155","doi-asserted-by":"publisher","unstructured":"He Y, Chen Y, Qian S, van Der Merwe S, Dhar D, Brenner DA, et al. Immunopathogenic mechanisms and immunoregulatory therapies in MASLD. Cell Mol Immunol. 2025. https:\/\/doi.org\/10.1038\/s41423-025-01307-5.","DOI":"10.1038\/s41423-025-01307-5"},{"key":"794_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/nu17132098","author":"EV Geladari","year":"2025","unstructured":"Geladari EV, Kounatidis D, Christodoulatos GS, Psallida S, Pavlou A, Geladari CV, et al. Ultra-processed foods and metabolic dysfunction-associated steatotic liver disease (MASLD): what is the evidence so far? Nutr. 2025. https:\/\/doi.org\/10.3390\/nu17132098.","journal-title":"Nutr"},{"key":"794_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136518","author":"K Drygalski","year":"2025","unstructured":"Drygalski K. Pharmacological treatment of MASLD: contemporary treatment and future perspectives. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26136518.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"794_CR158","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1038\/s41598-025-90419-z","volume":"15","author":"Q Li","year":"2025","unstructured":"Li Q, Xiang J. METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6a methylation of FAS. Sci Rep. 2025;15(1):6162.","journal-title":"Sci Rep"},{"issue":"6","key":"794_CR159","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s13577-021-00593-1","volume":"34","author":"L Cheng","year":"2021","unstructured":"Cheng L, Yu P, Li F, Jiang X, Jiao X, Shen Y, et al. Human umbilical cord-derived mesenchymal stem cell-exosomal miR-627-5p ameliorates non-alcoholic fatty liver disease by repressing FTO expression. Hum Cell. 2021;34(6):1697\u2013708.","journal-title":"Hum Cell"},{"key":"794_CR160","doi-asserted-by":"publisher","first-page":"102963","DOI":"10.1016\/j.redox.2023.102963","volume":"68","author":"T Jiang","year":"2023","unstructured":"Jiang T, Xiao Y, Zhou J, Luo Z, Yu L, Liao Q, et al. Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway. Redox Biol. 2023;68:102963.","journal-title":"Redox Biol"},{"issue":"1","key":"794_CR161","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41387-025-00355-0","volume":"15","author":"W Meng","year":"2025","unstructured":"Meng W, Li L. ZHX2 inhibits diabetes-induced liver injury and ferroptosis by epigenetic silence of YTHDF2. Nutr Diabetes. 2025;15(1):6.","journal-title":"Nutr Diabetes"},{"issue":"18","key":"794_CR162","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.3748\/wjg.v30.i18.2402","volume":"30","author":"D Usuda","year":"2024","unstructured":"Usuda D, Kaneoka Y, Ono R, Kato M, Sugawara Y, Shimizu R, et al. Current perspectives of viral hepatitis. World J Gastroenterol. 2024;30(18):2402\u201317.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"794_CR163","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.idc.2019.08.004","volume":"33","author":"S Lanini","year":"2019","unstructured":"Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33(4):1045\u201362.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"794_CR164","volume":"1865","author":"D Cheng","year":"2022","unstructured":"Cheng D, Wu C, Li Y, Liu Y, Mo J, Fu L, et al. METTL3 inhibition ameliorates liver damage in mouse with hepatitis B virus-associated acute-on-chronic liver failure by regulating miR-146a-5p maturation. Biochem Biophys Acta. 2022;1865(3):194782.","journal-title":"Biochem Biophys Acta"},{"issue":"1","key":"794_CR165","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41419-023-06412-9","volume":"15","author":"S Ding","year":"2024","unstructured":"Ding S, Liu H, Liu L, Ma L, Chen Z, Zhu M, et al. Epigenetic addition of m(5)C to HBV transcripts promotes viral replication and evasion of innate antiviral responses. Cell Death Dis. 2024;15(1):39.","journal-title":"Cell Death Dis"},{"issue":"6","key":"794_CR166","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202300059RR","volume":"37","author":"XS Pan","year":"2023","unstructured":"Pan XS, Li BW, Wang LL, Li N, Lin HM, Zhang J, et al. Kupffer cell pyroptosis mediated by METTL3 contributes to the progression of alcoholic steatohepatitis. FASEB J. 2023;37(6):e22965.","journal-title":"FASEB J"},{"key":"794_CR167","doi-asserted-by":"publisher","unstructured":"Yao J, Liu P, Teng X, Kong D, Han B, Cui C, et al. Alcohol-induced disruption of hepatic m 6 A modification exacerbates alcohol-associated steatohepatitis by impairing liver immune microenvironment homeostasis. Hepatology. 2025. https:\/\/doi.org\/10.1097\/HEP.0000000000001374.","DOI":"10.1097\/HEP.0000000000001374"},{"issue":"7","key":"794_CR168","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn P, Tacke F. Metabolic reprogramming in liver fibrosis. Cell Metab. 2024;36(7):1439\u201355.","journal-title":"Cell Metab"},{"issue":"1","key":"794_CR169","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/annurev-pharmtox-020524-012013","volume":"65","author":"H Gilgenkrantz","year":"2025","unstructured":"Gilgenkrantz H, Sayegh RA, Lotersztajn S. Immunoregulation of liver fibrosis: new opportunities for antifibrotic therapy. Annu Rev Pharmacol Toxicol. 2025;65(1):281\u201399.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"794_CR170","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/thno.106597","volume":"15","author":"M Yan","year":"2025","unstructured":"Yan M, Cui Y, Xiang Q. Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics. 2025;15(5):1715\u201340.","journal-title":"Theranostics"},{"key":"794_CR171","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fphar.2018.01516","volume":"9","author":"R Hu","year":"2018","unstructured":"Hu R, Jia WY, Xu SF, Zhu ZW, Xiao Z, Yu SY, et al. Xiaochaihutang Inhibits the activation of hepatic stellate cell line T6 through the Nrf2 pathway. Front Pharmacol. 2018;9:1516.","journal-title":"Front Pharmacol"},{"key":"794_CR172","doi-asserted-by":"publisher","first-page":"102151","DOI":"10.1016\/j.redox.2021.102151","volume":"47","author":"M Shen","year":"2021","unstructured":"Shen M, Li Y, Wang Y, Shao J, Zhang F, Yin G, et al. N(6)-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells. Redox Biol. 2021;47:102151.","journal-title":"Redox Biol"},{"key":"794_CR173","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2022.02.028","volume":"182","author":"M Shen","year":"2022","unstructured":"Shen M, Guo M, Li Y, Wang Y, Qiu Y, Shao J, et al. M(6)A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells. Free Radic Biol Med. 2022;182:246\u201359.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"794_CR174","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3724\/abbs.2024162","volume":"57","author":"W Liu","year":"2024","unstructured":"Liu W, He Y, Chen K, Ye J, Yu L, Zhou C, et al. YTHDF2 influences hepatic fibrosis by regulating ferroptosis in hepatic stellate cells by mediating the expression of ACSL4 in an m (6)A-dependent manner. Acta Biochim Biophys Sin. 2024;57(4):521\u20138.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"8","key":"794_CR175","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1793","volume":"14","author":"X Li","year":"2024","unstructured":"Li X, Li Y, Zhang W, Jiang F, Lin L, Wang Y, et al. The IGF2BP3\/Notch\/Jag1 pathway: a key regulator of hepatic stellate cell ferroptosis in liver fibrosis. Clin Transl Med. 2024;14(8):e1793.","journal-title":"Clin Transl Med"},{"issue":"3","key":"794_CR176","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42(3):629\u201352.","journal-title":"Cancer Metastasis Rev"},{"key":"794_CR177","doi-asserted-by":"publisher","first-page":"775462","DOI":"10.3389\/fcell.2021.775462","volume":"9","author":"X Hao","year":"2021","unstructured":"Hao X, Sun G, Zhang Y, Kong X, Rong D, Song J, et al. Targeting immune cells in the tumor microenvironment of HCC: new opportunities and challenges. Front Cell Dev Biol. 2021;9:775462.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"794_CR178","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-020-01172-y","volume":"19","author":"M Chen","year":"2020","unstructured":"Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer. 2020;19(1):44.","journal-title":"Mol Cancer"},{"key":"794_CR179","doi-asserted-by":"publisher","first-page":"102971","DOI":"10.1016\/j.redox.2023.102971","volume":"69","author":"Y Li","year":"2024","unstructured":"Li Y, Guo M, Qiu Y, Li M, Wu Y, Shen M, et al. Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma. Redox Biol. 2024;69:102971.","journal-title":"Redox Biol"},{"issue":"3","key":"794_CR180","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70270","volume":"15","author":"O Li","year":"2025","unstructured":"Li O, An K, Wang H, Li X, Wang Y, Huang L, et al. Targeting YBX1-m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma. Clin Transl Med. 2025;15(3):e70270.","journal-title":"Clin Transl Med"},{"key":"794_CR181","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjac061","author":"Z Tang","year":"2023","unstructured":"Tang Z, Sun C, Yan Y, Niu Z, Li Y, Xu X, et al. Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs. J Mol Cell Biol. 2023. https:\/\/doi.org\/10.1093\/jmcb\/mjac061.","journal-title":"J Mol Cell Biol"},{"issue":"1","key":"794_CR182","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/gutjnl-2024-331903","volume":"74","author":"A Chen","year":"2024","unstructured":"Chen A, Zhang VX, Zhang Q, Sze KM, Tian L, Huang H, et al. Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma. Gut. 2024;74(1):90\u2013102.","journal-title":"Gut"},{"issue":"43","key":"794_CR183","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1021\/ja3064149","volume":"134","author":"B Chen","year":"2012","unstructured":"Chen B, Ye F, Yu L, Jia G, Huang X, Zhang X, et al. Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. J Am Chem Soc. 2012;134(43):17963\u201371.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"794_CR184","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang Y, Yan J, Li Q, Li J, Gong S, Zhou H, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015;43(1):373\u201384.","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"794_CR185","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1021\/acs.accounts.3c00451","volume":"56","author":"Y Huang","year":"2023","unstructured":"Huang Y, Xia W, Dong Z, Yang CG. Chemical inhibitors targeting the oncogenic m(6)a modifying proteins. Acc Chem Res. 2023;56(21):3010\u201322.","journal-title":"Acc Chem Res"},{"issue":"4","key":"794_CR186","doi-asserted-by":"publisher","first-page":"115300","DOI":"10.1016\/j.bmc.2019.115300","volume":"28","author":"A Malacrida","year":"2020","unstructured":"Malacrida A, Rivara M, Di Domizio A, Cislaghi G, Miloso M, Zuliani V, et al. 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line. Bioorg Med Chem. 2020;28(4):115300.","journal-title":"Bioorg Med Chem"},{"key":"794_CR187","doi-asserted-by":"publisher","first-page":"114446","DOI":"10.1016\/j.ejmech.2022.114446","volume":"238","author":"Z Fang","year":"2022","unstructured":"Fang Z, Mu B, Liu Y, Guo N, Xiong L, Guo Y, et al. Discovery of a potent, selective and cell active inhibitor of m(6)A demethylase ALKBH5. Eur J Med Chem. 2022;238:114446.","journal-title":"Eur J Med Chem"},{"issue":"8","key":"794_CR188","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.xcrm.2023.101144","volume":"4","author":"Y Pan","year":"2023","unstructured":"Pan Y, Chen H, Zhang X, Liu W, Ding Y, Huang D, et al. METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy. Cell Rep Med. 2023;4(8):101144.","journal-title":"Cell Rep Med"},{"key":"794_CR189","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2024.2447056","author":"Z Wu","year":"2024","unstructured":"Wu Z, Smith AR, Qian Z, Zheng G. Patent landscape of small molecule inhibitors of METTL3 (2020-present). Expert Opin Ther Pat. 2024. https:\/\/doi.org\/10.1080\/13543776.2024.2447056.","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"794_CR190","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1136\/gutjnl-2023-330459","volume":"73","author":"A Olazagoitia-Garmendia","year":"2024","unstructured":"Olazagoitia-Garmendia A, Rojas-M\u00e1rquez H, Romero MDM, Ruiz P, Agirre-Lizaso A, Chen Y, et al. Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation. Gut. 2024;73(9):1590\u20132.","journal-title":"Gut"},{"issue":"12","key":"794_CR191","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, et al. The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40(12):1566-82.e10.","journal-title":"Cancer Cell"},{"key":"794_CR192","doi-asserted-by":"publisher","first-page":"101181","DOI":"10.1016\/j.drup.2024.101181","volume":"78","author":"CJ Shi","year":"2025","unstructured":"Shi CJ, Pang FX, Lei YH, Deng LQ, Pan FZ, Liang ZQ, et al. 5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis. Drug Resist Updat. 2025;78:101181.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"794_CR193","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-025-03277-y","volume":"44","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Song D, Guo M, Wang C, Ma M, Tao G, et al. EGFR inhibition augments the therapeutic efficacy of the NAT10 inhibitor Remodelin in colorectal cancer. J Exp Clin Cancer Res. 2025;44(1):37.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"794_CR194","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","volume":"83","author":"R Xie","year":"2023","unstructured":"Xie R, Cheng L, Huang M, Huang L, Chen Z, Zhang Q, et al. NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer. Cancer Res. 2023;83(10):1666\u201383.","journal-title":"Cancer Res"},{"issue":"10","key":"794_CR195","doi-asserted-by":"publisher","first-page":"2004344","DOI":"10.1002\/advs.202004344","volume":"8","author":"G Kan","year":"2021","unstructured":"Kan G, Wang Z, Sheng C, Chen G, Yao C, Mao Y, et al. Dual inhibition of DKC1 and MEK1\/2 synergistically restrains the growth of colorectal cancer cells. Adv Sci. 2021;8(10):2004344.","journal-title":"Adv Sci"},{"issue":"18","key":"794_CR196","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1038\/s41388-020-1248-x","volume":"39","author":"J Ram\u00edrez-Moya","year":"2020","unstructured":"Ram\u00edrez-Moya J, Baker AR, Slack FJ, Santisteban P. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene. 2020;39(18):3738\u201353.","journal-title":"Oncogene"},{"issue":"1","key":"794_CR197","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12935-021-01868-1","volume":"21","author":"W Zhu","year":"2021","unstructured":"Zhu W, Wang JZ, Wei JF, Lu C. Role of m6A methyltransferase component VIRMA in multiple human cancers (review). Cancer Cell Int. 2021;21(1):172.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"794_CR198","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19(1):88.","journal-title":"Mol Cancer"},{"issue":"1","key":"794_CR199","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","volume":"49","author":"G Zheng","year":"2013","unstructured":"Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18\u201329.","journal-title":"Mol Cell"},{"key":"794_CR200","doi-asserted-by":"publisher","first-page":"1153463","DOI":"10.3389\/fonc.2023.1153463","volume":"13","author":"Q Li","year":"2023","unstructured":"Li Q, Zhu Q. The role of demethylase AlkB homologs in cancer. Front Oncol. 2023;13:1153463.","journal-title":"Front Oncol"},{"issue":"1","key":"794_CR201","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-022-00269-y","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Zhou X, Wang X. m(6)A binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022;11(1):21.","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"794_CR202","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050128","volume":"22","author":"TL Xia","year":"2021","unstructured":"Xia TL, Li X, Wang X, Zhu YJ, Zhang H, Cheng W, et al. N(6)-methyladenosine-binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay. EMBO Rep. 2021;22(4):e50128.","journal-title":"EMBO Rep"},{"issue":"1","key":"794_CR203","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12967-024-05293-6","volume":"22","author":"X Wu","year":"2024","unstructured":"Wu X, Chen H, Li K, Zhang H, Li K, Tan H. The biological function of the N6-methyladenosine reader YTHDC2 and its role in diseases. J Transl Med. 2024;22(1):490.","journal-title":"J Transl Med"},{"issue":"2","key":"794_CR204","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR. Reading m(6)A in the transcriptome: m(6)a-binding proteins. Trends Cell Biol. 2018;28(2):113\u201327.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"794_CR205","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W. M(6)A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol. 2020;13(1):35.","journal-title":"J Hematol Oncol"},{"issue":"7919","key":"794_CR206","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04898-5","volume":"607","author":"S Delaunay","year":"2022","unstructured":"Delaunay S, Pascual G, Feng B, Klann K, Behm M, Hotz-Wagenblatt A, et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nat. 2022;607(7919):593\u2013603.","journal-title":"Nat"},{"issue":"2","key":"794_CR207","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004110","volume":"10","author":"MD Metodiev","year":"2014","unstructured":"Metodiev MD, Sp\u00e5hr H, Loguercio Polosa P, Meharg C, Becker C, Altmueller J, et al. NSUN4 is a dual function mitochondrial protein required for both methylation of 12S rRNA and coordination of mitoribosomal assembly. PLoS Genet. 2014;10(2):e1004110.","journal-title":"PLoS Genet"},{"issue":"9","key":"794_CR208","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/1878-0261.13434","volume":"17","author":"J Zhou","year":"2023","unstructured":"Zhou J, Kong YS, Vincent KM, Dieters-Castator D, Bukhari AB, Glubrecht D, et al. RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma. Mol Oncol. 2023;17(9):1763\u201383.","journal-title":"Mol Oncol"},{"issue":"2","key":"794_CR209","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/nar\/gkaa1193","volume":"49","author":"T Selmi","year":"2021","unstructured":"Selmi T, Hussain S, Dietmann S, Hei\u00df M, Borland K, Flad S, et al. Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6. Nucleic Acids Res. 2021;49(2):1006\u201322.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"794_CR210","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-023-01785-z","volume":"22","author":"V Ortiz-Barahona","year":"2023","unstructured":"Ortiz-Barahona V, Soler M, Davalos V, Garc\u00eda-Prieto CA, Janin M, Setien F, et al. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Mol Cancer. 2023;22(1):83.","journal-title":"Mol Cancer"},{"key":"794_CR211","doi-asserted-by":"publisher","first-page":"107222","DOI":"10.1016\/j.phrs.2024.107222","volume":"205","author":"H Li","year":"2024","unstructured":"Li H, Liu H, Zhu D, Dou C, Gang B, Zhang M, et al. Biological function molecular pathways and druggability of DNMT2\/TRDMT1. Pharmacol Res. 2024;205:107222.","journal-title":"Pharmacol Res"},{"key":"794_CR212","doi-asserted-by":"publisher","first-page":"110645","DOI":"10.1016\/j.biopha.2020.110645","volume":"131","author":"MZ Xiao","year":"2020","unstructured":"Xiao MZ, Liu JM, Xian CL, Chen KY, Liu ZQ, Cheng YY. Therapeutic potential of ALKB homologs for cardiovascular disease. Biomed Pharmacother. 2020;131:110645.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"794_CR213","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.gendis.2015.05.001","volume":"2","author":"L Prabhu","year":"2015","unstructured":"Prabhu L, Hartley AV, Martin M, Warsame F, Sun E, Lu T. Role of post-translational modification of the Y box binding protein 1 in human cancers. Genes Dis. 2015;2(3):240\u20136.","journal-title":"Genes Dis"},{"issue":"13","key":"794_CR214","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.molcel.2024.06.013","volume":"84","author":"TY Lin","year":"2024","unstructured":"Lin TY, Kleemann L, Je\u017cowski J, Dobosz D, Rawski M, Indyka P, et al. The molecular basis of tRNA selectivity by human pseudouridine synthase 3. Mol Cell. 2024;84(13):2472-89.e8.","journal-title":"Mol Cell"},{"issue":"9","key":"794_CR215","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43018-021-00238-0","volume":"2","author":"Q Cui","year":"2021","unstructured":"Cui Q, Yin K, Zhang X, Ye P, Chen X, Chao J, et al. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis. Nat Cancer. 2021;2(9):932\u201349.","journal-title":"Nat Cancer"},{"issue":"20","key":"794_CR216","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1016\/j.jmb.2013.05.022","volume":"425","author":"R Kamalampeta","year":"2013","unstructured":"Kamalampeta R, Keffer-Wilkes LC, Kothe U. TRna binding, positioning, and modification by the pseudouridine synthase Pus10. J Mol Biol. 2013;425(20):3863\u201374.","journal-title":"J Mol Biol"},{"issue":"8","key":"794_CR217","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043147","volume":"7","author":"B Liu","year":"2012","unstructured":"Liu B, Zhang J, Huang C, Liu H. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis. PLoS ONE. 2012;7(8):e43147.","journal-title":"PLoS ONE"},{"issue":"7","key":"794_CR218","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/CAD.0000000000001608","volume":"35","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zhou L, Yang J, Lu J, Tao L, Feng Y, et al. Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT\/mTOR. Anticancer Drugs. 2024;35(7):597\u2013605.","journal-title":"Anticancer Drugs"},{"key":"794_CR219","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.70004","author":"B He","year":"2025","unstructured":"He B, Hu Y, Wu Y, Wang C, Gao L, Gong C, et al. Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a \u201chit-and-run\u201d paradigm. Cancer Commun. 2025. https:\/\/doi.org\/10.1002\/cac2.70004.","journal-title":"Cancer Commun"},{"issue":"15","key":"794_CR220","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/ijbs.77774","volume":"18","author":"Y Xu","year":"2022","unstructured":"Xu Y, Zhou J, Li L, Yang W, Zhang Z, Zhang K, et al. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. Int J Biol Sci. 2022;18(15):5943\u201362.","journal-title":"Int J Biol Sci"},{"key":"794_CR221","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097957","author":"Q Yang","year":"2023","unstructured":"Yang Q, Al-Hendy A. The functional role and regulatory mechanism of FTO m(6)a RNA demethylase in human uterine leiomyosarcoma. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24097957.","journal-title":"Int J Mol Sci"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00794-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00794-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00794-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:06:05Z","timestamp":1759921565000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00794-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":221,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00794-8","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}